| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/27/2006 | US20060088835 Schizophrenia associated genes |
| 04/27/2006 | US20060088824 Used in assays to identify PAP-1/WIP-1 interaction inhibitors; West Nile virus (WNV) |
| 04/27/2006 | US20060088820 Detecting superantigen activity in a biological sample |
| 04/27/2006 | US20060088614 Compounds, compositions and methods for treating neuropsychiatric disorders |
| 04/27/2006 | US20060088613 Simmondsin for use as angiogenesis inhibitor |
| 04/27/2006 | US20060088610 Anti-inflammatory cranberry flavonol extract preparations |
| 04/27/2006 | US20060088607 Nutritional supplement compositions |
| 04/27/2006 | US20060088606 Methods and compositions for use in perfusion applications |
| 04/27/2006 | US20060088604 Therapeutic ointment for treating dermatological infections and method of using same |
| 04/27/2006 | US20060088603 Compositions and methods for nutrition supplementation |
| 04/27/2006 | US20060088600 includes the optimal blend of omega-3 and omega-6 essential fatty acids, and nutrient cofactors necessary to enhance the metabolic conversion associated with the tear-specific series E-one anti-inflammatory prostaglandin |
| 04/27/2006 | US20060088598 Intravenous composition, process for producing the same and preparation thereof |
| 04/27/2006 | US20060088584 Storage stability; freeze drying; mixture containing phospholipids and monosaccharides; regenerated as aqueous solution;administering by injection |
| 04/27/2006 | US20060088583 Artificial oxygen carrier containing preventive agents of metHb formation |
| 04/27/2006 | US20060088580 Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion |
| 04/27/2006 | US20060088576 Method for enhancing milk production |
| 04/27/2006 | US20060088573 Composition having action preventing or alleviating symtoms or diseases due to aging of blood vessels |
| 04/27/2006 | US20060088565 Device having osteoinductive and osteoconductive properties |
| 04/27/2006 | US20060088561 solidifying agent consists of long chain fatty alcohol; carrier is semi-solid at rest and liquefies upon application of shear forces |
| 04/27/2006 | US20060088558 Vitamin E TPGS fluid concentrate comprising a low percentage of water |
| 04/27/2006 | US20060088556 Topical formulation and use of buspirone |
| 04/27/2006 | US20060088553 Medicament for the treatment of diseases due to infection by neisseria meningitidis |
| 04/27/2006 | US20060088550 Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof |
| 04/27/2006 | US20060088545 Use of inhibitors of the protease of the human immunodeficiency virus (hiv) to block cell migration and/or invasion, tissue infiltration and oedema for the therary of diseases associated therewith |
| 04/27/2006 | US20060088542 Imidazoquinoline adjuvants for vaccines |
| 04/27/2006 | US20060088540 Antagonists and methods for inhibiting angiogenesis |
| 04/27/2006 | US20060088535 Method for enhancing long-term memory in a subject and uses thereof |
| 04/27/2006 | US20060088532 Lymphatic and blood endothelial cell genes |
| 04/27/2006 | US20060088530 Administering lyposomes of photosensitive receptors or ligands targeted to specific tissues, exposure to light causing destruction of bound tissues; treatment of eye neovascular disease due to macular degeneration, diabetes |
| 04/27/2006 | US20060088523 Antibody formulations |
| 04/27/2006 | US20060088517 Compounds and methods for treating seizure disorders |
| 04/27/2006 | US20060088512 Treatment of T cell disorders |
| 04/27/2006 | US20060088511 Cancer therapy sensitizer |
| 04/27/2006 | US20060088507 Rhodamine derivatives for photodynamic diagnosis and treatment |
| 04/27/2006 | US20060088502 Drug for reducing side effects in ribavirin interferon combination therapy |
| 04/27/2006 | US20060088491 Novel polyol-glycoside compositions for the skin |
| 04/27/2006 | US20060088485 Piperonyl alcohol; storage stability |
| 04/27/2006 | US20060088481 Topical oral dosage forms containing bismuth compounds |
| 04/27/2006 | US20060088477 Compositions and Methods of Dispensing Palliative or Therapeutic Agents |
| 04/27/2006 | DE4215450B4 Topische Pharmazeutische Mittel und Verfahren zu ihrer Herstellung A topical pharmaceutical means and methods for their preparation |
| 04/27/2006 | DE10235475B4 Arzneimittel mit einer Benzimidazolverbindung im Gemisch mit mikrokristalliner Cellulose und Verfahren zu deren Herstellung Drugs with a benzimidazole compound in mixture with microcrystalline cellulose and process for their preparation |
| 04/27/2006 | DE102004051804A1 Beta-L-N4-Hydroxycytosin-Desoxynucleoside und ihre Verwendung als pharmazeutische Mittel zur Prophylaxe oder Therapie von viralen Erkrankungen Beta-L-N4-hydroxycytosine-deoxynucleosides and their use as pharmaceutical agents for the prophylaxis or therapy of viral diseases |
| 04/27/2006 | DE102004051554A1 Verfahren zur Herstellung von pigmenthaltigen Minen Process for preparing pigment-containing mines |
| 04/27/2006 | DE102004051277A1 Heterocyclische Carbonylverbindungen Heterocyclic carbonyl |
| 04/27/2006 | DE102004051245A1 Vitamin C-Solubilisat Vitamin C Solubilisate |
| 04/27/2006 | DE102004051188A1 Cyanothiophene, deren Herstellung und deren Verwendung als Arzneimittel Cyanothiophenes, their preparation and their use as medicaments |
| 04/27/2006 | DE102004050283A1 4-Aminophenyl-morpholinon-Derivate und deren Herstellung 4-aminophenyl-morpholinone derivatives and their preparation |
| 04/27/2006 | DE10164687B4 Crystalline citalopram base and salts with high purity useful for treatment of depression |
| 04/27/2006 | DE10034494B4 Verfahren zur Herstellung eines Extrakts von amerikanischem Ginseng Process for the preparation of an extract from American ginseng |
| 04/27/2006 | CA2749235A1 Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cgmp phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women |
| 04/27/2006 | CA2626425A1 Anti-stress formula for human and veterinary use |
| 04/27/2006 | CA2626363A1 Compositions and methods for prolonging survival of platelets |
| 04/27/2006 | CA2595212A1 Nutrient supplement and use of the same |
| 04/27/2006 | CA2584918A1 Cyanothiophenes, the production thereof and their use as medicaments |
| 04/27/2006 | CA2584866A1 Mitotic kinesin inhibitors and methods of use thereof |
| 04/27/2006 | CA2584854A1 Carbamate compounds for use in treating neurodegenerative disorders |
| 04/27/2006 | CA2584774A1 2-amido-4-phenylthiazole derivatives, the preparation and the therapeutic use thereof |
| 04/27/2006 | CA2584747A1 Treatment of osteoarthritis and dosing regimen for arzoxifene |
| 04/27/2006 | CA2584702A1 Nitrobenzindoles and their use in cancer therapy |
| 04/27/2006 | CA2584670A1 Combination therapy for treating viral infections |
| 04/27/2006 | CA2584655A1 Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating inflammatory bowel disease |
| 04/27/2006 | CA2584651A1 Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds |
| 04/27/2006 | CA2584610A1 Novel dicarboxylic acid derivatives |
| 04/27/2006 | CA2584550A1 Orally effective cannabinoid analogs |
| 04/27/2006 | CA2584537A1 Formulations containing alkylphosphocholines using novel negative charge carriers |
| 04/27/2006 | CA2584519A1 Method for modification of gamma-secretase activity through inhibition of fkbp13 |
| 04/27/2006 | CA2584507A1 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases |
| 04/27/2006 | CA2584504A1 Piperidines and related compounds for treatment of alzheimer's disease |
| 04/27/2006 | CA2584485A1 Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases |
| 04/27/2006 | CA2584459A1 Modulation of neuroglia-derived bdnf in the treatment and prevention of pain |
| 04/27/2006 | CA2584422A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 04/27/2006 | CA2584415A1 Topical treatment with ngf and dha in damaged corneas |
| 04/27/2006 | CA2584398A1 Ester derivative and pharmaceutical use thereof |
| 04/27/2006 | CA2584385A1 Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same |
| 04/27/2006 | CA2584383A1 Methods of using fatty-acid esters of estrogens and serotonin reuptake inhibiting compounds for reducing the body weight of a mammal and compositions containing the same |
| 04/27/2006 | CA2584368A1 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase |
| 04/27/2006 | CA2584342A1 Improved inhibitors for the soluble epoxide hydrolase |
| 04/27/2006 | CA2584333A1 Neuroprotective spirostenol pharmaceutical compositions |
| 04/27/2006 | CA2584328A1 Phosphodiesterase 4 inhibitors |
| 04/27/2006 | CA2584317A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 04/27/2006 | CA2584299A1 Methods and compositions for protecting cells from ultrasound-mediated cytolysis |
| 04/27/2006 | CA2584284A1 A method of reducing drug-induced adverse side effects in a patient |
| 04/27/2006 | CA2584262A1 Diphenyl substituted alkanes as flap inhiibitors |
| 04/27/2006 | CA2584248A1 Methods of treating vascular injuries |
| 04/27/2006 | CA2584209A1 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 04/27/2006 | CA2584207A1 Antiviral oligonucleotides |
| 04/27/2006 | CA2584195A1 Use of purine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells |
| 04/27/2006 | CA2584184A1 Methods and compositions for reducing toxicity of a pharmaceutical compound |
| 04/27/2006 | CA2584178A1 Use of paullone derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells |
| 04/27/2006 | CA2584170A1 Phenylurea derivatives as inhibitors of tyrosine kinases for the treatment of tumour diseases |
| 04/27/2006 | CA2584151A1 Method of treating human preeclampsia employing resibufagenin |
| 04/27/2006 | CA2584138A1 Methods and compositions for treatment of free radical injury |
| 04/27/2006 | CA2584124A1 Flavonoid composition for treating oral diseases |
| 04/27/2006 | CA2584041A1 Biphenyl integrin antagonists |
| 04/27/2006 | CA2584030A1 Anticancer compounds and methods |
| 04/27/2006 | CA2583986A1 Method of preventing and treating airway remodeling and pulmonary inflammation using a2b adenosine receptor antagonists |
| 04/27/2006 | CA2583976A1 Use of defined compounds for the manufacture of a medicament for preventing/treating diseases resulting from somatic mutations |
| 04/27/2006 | CA2583971A1 Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation-related diseases |
| 04/27/2006 | CA2583943A1 Novel curcumin analogues and uses thereof |
| 04/27/2006 | CA2583828A1 Carboxylic acid peri-substituted bicyclics for occlusive artery disease |